Clinical Trials
All Clinical Trials - Page 32 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03947762N/ATerminated
Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.
Lanreotide
- NCT03970044Phase 4Completed
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Exenatide
- NCT03989024Phase 4Unknown
Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome
Gonadorelin
- NCT03994172Phase 4Active Not Recruiting
Novel Combination Therapy for Osteoporosis in Men
Teriparatide
- NCT01311518Phase 2Withdrawn
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
TB-500
- NCT04003467Phase 2Completed
A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass
Teriparatide
- NCT03951753Phase 1Completed
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
Tirzepatide
- NCT04027348Phase 2Terminated
Palliative Management of Inoperable Malignant Bowel Obstruction
Octreotide
- NCT03948347N/AUnknown
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03421119Phase 3Unknown
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
Liraglutide
- NCT03989232Phase 3Completed
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Semaglutide
- NCT03987451Phase 2Completed
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Semaglutide
- NCT03914326Phase 3Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Semaglutide
- NCT03973047Phase 1Completed
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
PT-141
- NCT03879694Phase 1Completed
Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Octreotide
- NCT03946527Phase 2Active Not Recruiting
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
Lanreotide
- NCT03929744Phase 1Completed
A Study of LY3502970 in Healthy Participants
Orforglipron
- NCT03981627Phase 1/Phase 2Completed
A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT03954834Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Tirzepatide
- NCT03962010Phase 2Unknown
A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
Dulaglutide
- NCT04206618N/ACompleted
Circulating Myokine Levels and Bone Metabolism
Teriparatide
- NCT04126941N/AUnknown
Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism
Teriparatide
- NCT03929679N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
Semaglutide
- NCT03937882Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
TB-500
- NCT03923114N/ACompleted
Imaging Pituitary ActiVation by Exendin
Exenatide
- NCT05029076Phase 1Completed
Human Bioequivalence Test of Liraglutide Injection
Liraglutide
- NCT04019197Phase 2Active Not Recruiting
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Semaglutide
- NCT03951831Phase 2Active Not Recruiting
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
Gonadorelin
- NCT03961256Phase 2Completed
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
Exenatide
- NCT03861052Phase 3Completed
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
Tirzepatide
- NCT04185350EARLY_Phase 1Unknown
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Exenatide
- NCT03919929Phase 2/Phase 3Completed
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide
- NCT04648969Phase 2Completed
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Kisspeptin
- NCT03645408Phase 1Terminated
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Exenatide
- NCT03899402Phase 2/Phase 3Active Not Recruiting
Triple Therapy in T1DM
Semaglutide
- NCT03940495N/ACompleted
Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
Kisspeptin
- NCT04034524N/AUnknown
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
Liraglutide
- NCT03860688Phase 2/Phase 3Unknown
Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
Teduglutide
- NCT03985384Phase 4Completed
Semaglutide Treatment On Coronary Progression
Semaglutide
- NCT03860987Phase 2Completed
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
Gonadorelin
- NCT03914651N/AUnknown
CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU
Gonadorelin
- NCT03862716Phase 3Completed
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
Liraglutide
- NCT03883776Phase 1Completed
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
Octreotide
- NCT04366726Phase 1Completed
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
Abaloparatide
- NCT03899077Phase 2Unknown
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
Gonadorelin
- NCT03882970Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Tirzepatide
- NCT03878381EARLY_Phase 1Completed
Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream
Argireline
- NCT03696121Phase 2Completed
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
Desmopressin
- NCT03861039Phase 3Completed
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Tirzepatide
- NCT03891875Phase 2Completed
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
Elamipretide